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Abstract
Background: Pancreatic ductal adenocarcinoma has dismal prognosis. Most patients receive radiation therapy (RT),
which is complicated by respiration induced organ motion in upper abdomen. The purpose of this study is to
report our early clinical experience in a novel self-gated k-space sorted four-dimensional magnetic resonance
imaging (4D-MRI) with slab-selective (SS) excitation to highlight tumor infiltrating blood vessels for pancreatic RT.
Methods: Ten consecutive patients with borderline resectable or locally advanced pancreatic cancer were recruited
to the study. Non-contrast 4D-MRI with and without slab-selective excitation and 4D-CT with delay contrast were
performed on all patients. Vessel-tissue CNR were calculated for aorta and critical vessels (superior mesenteric artery
or superior mesenteric vein) encompassed by tumor. Respiratory motion trajectories for tumor, as well as involved
vessels were analyzed on SS-4D-MRI. Intra-class cross correlation (ICC) between tumor volume and involved vessels
were calculated.
Results: Among all 4D imaging modalities evaluated, SS-4D-MRI sampling trajectory results in images with highest
vessel-tissue CNR comparing to non-slab-selective 4D-MRI and 4D-CT for all patients studied. Average (±standard
deviation) CNR for involved vessels are 13.1 ± 8.4 and 3.2 ± 2.7 for SS-4D-MRI and 4D-CT, respectively. The ICC
factors comparing tumor and involved vessels motion trajectories are 0.93 ± 0.10, 0.65 ± 0.31 and 0.77 ± 0.23 for
superior-inferior, anterior-posterior and medial-lateral directions respectively.
Conclusions: A novel 4D-MRI sequence based on 3D-radial sampling and slab-selective excitation has been
assessed for pancreatic cancer patients. The non-contrast 4D-MRI images showed significantly better contrast to
noise ratio for the vessels that limit tumor resectability compared to 4D-CT with delayed contrast. The sequence
has great potential in accurately defining both the tumor and boost volume margins for pancreas RT with
simultaneous integrated boost.
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Introduction
Pancreatic ductal adenocarcinoma (PDA) has the worst
outcome of any solid tumor [1]. Whereas surgical resection
remains the mainstay therapy, 80% of patients with
non-metastatic disease have unresectable tumors that are
unlikely to be down-staged after standard chemo-radiation
therapy, due to the geometric relationship of the primary
tumor to the surrounding vasculature [2]. Nevertheless, the
overall survival rates in the patient group undergoing mar-
gin negative resection after neoadjuvant therapy are 2–3
times of the unresectable patient group [3, 4]. Stereotactic
body radiation therapy (SBRT) has shown to improve local
tumor control rates, yet has disappointing down-staging
rates. Alternatively, radiation therapy (RT) with simultan-
eous integrated boost (SIB) to cancerous tissue surrounding
tumor infiltrating vasculature has the potential to sterilize
tumor around the vessels that have precluded resectability
[5, 6]. However there are significant technical challenges as-
sociated with accurately escalating (boosting) radiation dose
to the vessel/tumor interface due to substantial internal
organ motion in the upper abdominal region. [7–10] SBRT
with SIB to tumor/vessel interface is further complicated by
the fact that the motion of the cancerous tissue surround-
ing the tumor infiltrating vessels may be different from cen-
ter of the pancreas tumor [11]. Per standard clinical
practice in our institution, a free-breathing (FB) contrast
enhanced helical CT and a four dimensional CT (4D-CT)
are performed to quantify the motion. Depending on pa-
tient compliance, 4D-CT can either be performed right
after FB-CT with a sufficient amount of contrast left over
in the blood vessels to enhance vasculature visibility, or
after a long breathing coaching session to reach a stable
respiration pattern required for a successful 4D-CT acquisi-
tion, when the contrast in the region of interest has already
diminished. Risks associated with radiation dose and con-
trast agents also prevent this procedure from being repeti-
tively performed on patients. [12, 13] The problem is
further compounded by poor CT soft tissue contrast and
4D-CT stitching artifacts [14]. For these reasons, 4D-CT
with delayed intravenous and oral contrasts often has lim-
ited value to evaluate soft tissue and blood vessel respira-
tory motion.
Recently the interest in using magnetic resonance im-
aging (MRI) in pancreas radiotherapy has increased. The
superior soft tissue contrast and versatile imaging se-
quences of MRI can facilitate margin definitions in
SBRT-SIB. Frequent imaging procedures necessary for
organ motion characterization are also impeded by radi-
ation dose from 4D-CT while not an issue in MRI. Since
current MRI speed is insufficient to capture the
three-dimensional motion of upper abdominal organs in
real time, four dimensional MRI (4D-MRI) was devel-
oped to reconstruct motion encoded images from mul-
tiple breathing cycles. Early 4D-MRI was reconstructed
by sorting 2D cine images from consecutive slices, thus
its quality was degraded by severe stitching artifacts
[15–17]. The artifacts were eliminated with new
4D-MRI techniques based on 3D acquisition sequences
[18] and k-space sorting such as the recently developed
self-gated 4D-MRI technique with 3D radial sampling
and k-space sorting [16, 19]. The new class of 4D-MRI
sequences also provides high isotropic resolution that
was unachievable with 2D cine based 4D-MRI.
Recently, slab-selective excitation was proposed to im-
prove vessel-tissue contrast and overall image quality in
3D radial-sampling-based 4D-MRI [20]. This approach
exploits the in-flow effect. As fresh blood first enters the
imaging volume of interest and experiences fewer
RF-pulses than stationary tissues, blood signal is mark-
edly higher than that of tissue, creating appreciable
vessel-tissue contrast for various types of cancers includ-
ing the pancreatic cancer. However, its ability of quanti-
fying the pancreatic tumor and tumor infiltrating vessel
motion has not been studied and compared with the
current state of the art method 4D-CT.
To quantify this ability, the current study aims to ex-
ploit the technological potential of contrast free vessel
highlighting in combination with the high resolution
4D-MRI method for a pancreatic patient cohort. The
goal is to show the reproducibility and consistency of
this novel 4D-MR method. Through the comparison
with 4D-CT, we specifically evaluate the respiratory mo-
tion trajectories for both the tumor and the tumor infil-
trating blood vessels that used to define potential boost
volumes in the pancreas SIB treatment.
Methods and materials
Patients
Ten consecutive patients (seven males and three fe-
males, average age of 65) diagnosed with locally ad-
vanced, borderline resectable or locally recurrent PDA
were recruited for the study under a protocol approved
by the institutional review board. Gross tumor volumes
range from 14 to 220 cc (mean ± σ = 86 ± 56 cc).
Imaging studies
The 4D-MRI sequence was described in details in previ-
ous publications [16]. In short, an in-house developed,
RF and spoiled gradient recalled echo (GRE) sequence
with Koosh-Ball (KB) 3D k-space radial-sampling trajec-
tory, 1D self-gating and slab-selective (SS) excitation was
implemented at 3 T (Biograph mMR, Siemens Healthi-
neers. USA). Amplitude based sorting was applied in
k-space before image reconstruction. This sequence is
denoted as SS-4D-MRI. KB 4D-MRI with non-selective
excitation was also performed and denoted as
NS-4D-MRI. The shared imaging protocol for SS and
NS were as follows: field of view (FOV) = (400 mm) [3];
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prescribed spatial resolution =1.56 mm; flip angle = 12o;
repetition time (TR)/echo time (TE) = 5.5/2.68 ms; read-
out bandwidth = 429 Hz/pixel; fat suppression with
water excitation on; total scan time = 5 min. Patients
were lying on the imaging couch in the head first supine
position, with arms placed on the side for the comfort.
No special immobilization was used.
During the patient’s clinical CT simulation visit, a
standard contrast enhanced FB-CT scan was first per-
formed on a 16-slice scanner (Optima CT580; GE
Healthcare, Milwaukee, WI), followed by a 4D-CT scan.
Cine mode was used for the 4D-CT with the following
parameters: 120 kV, variable mA, gantry rotation period
of 1 s, and slice thickness of 2.5 mm. The cine duration
was set to be the patient’s breathing period plus 1.5 s. A
total of 3000 images were set as the limit, which typically
covers the region from above the diaphragm down to
below the distal portion of the kidneys. 4D-CT images
were then retrospectively binned using phase based sort-
ing method in AdvantageSim™ 4D software (GE Health-
care, Milwaukee, WI). Variable time gaps ranging from
5 min to 30 min between the first contrast FB-CT scan
and the following 4D-CT scan had to be used depending
on the individual patient’s compliance with the audio
coaching of the respiration. Patients were immobilized
in a vacuum lock bag and simulated in a head-first su-
pine position with both arms raised above the head.
Image analysis
Pancreatic tumor and the involving blood vessels were de-
lineated on the end-of-exhalation image bin by a single ra-
diation oncologist. A B-spline based image registration
was performed on both the 4D-MRI and 4D-CT using
VelocityAI™ (Varian Medical System, Palo Alto, CA). Con-
tours were mapped to the other bins. Motion trajectories
for both the tumor and the tumor infiltrating blood ves-
sels were extracted by the coordinates of the geometric
centers from each respiration bin. The correlation coeffi-
cient (CC) was calculated from the tumor and the in-
volved vessel motion trajectories for each patient.
Vessel-tissue contrast to noise ratio (CNR) is defined
as CNR ¼ jSV−SP jσL in which SV is the average intensity of a
selected region in the vessel, SP is the average intensity
of the adjacent region in the pancreas tumor and σL is
the standard deviation of a relatively homogeneous re-
gion in the liver. Two CNRs, the aorta (CNRaorta) and
tumor infiltration blood vessel (CNRIV), were calculated
on both the 4D-MRI and 4D-CT.
Results
SS-4D-MRI was successfully implemented on 10 pancre-
atic cancer patients. All scans resulted consistent and
satisfactory imaging quality.
Figure 1 shows an example patient’s SS-4D-MRI in
three cardinal planes (coronal, sagittal and axial). Excel-
lent image quality and high isotropic image resolution
(1.6 mm) are achieved in all planes. Fine image features
such as blood vessels in the liver, stomach wall, dia-
phragm and bifurcation of the blood vessels from the
great vessels are all visible in 4D-MRI images. Red cir-
cles show the tumor region and green arrows show the
tumor infiltrating blood vessels. Excellent vessel contrast
was also observed in all three planes.
Figure 2 shows an example patient’s SS-4D-MRI in the
coronal plane at end-of-inhalation (EOI), mid-ventilation
and end-of-exhalation (EOE) bins (Fig. 2a-c), respect-
ively. The patient’s diaphragm motion is readily visible
using a white dashed straight line as the reference. Mo-
tion trajectories extracted from the center of mass coor-
dinates for both the tumor and involved vessel contours
were plotted for the superior-interior (SI),
anterior-posterior (AP) and medial-lateral (ML) direc-
tions (Fig. 2d-f ). For this patient, tumor and involved
vessel movements correlate well in the SI direction, but
less well in the AP and ML directions, possibly due to
the small motion amplitudes (< 1.6 mm, the image reso-
lution) observed in these two directions.
Figure 3 shows the comparisons of SS-4D-MRI (a) to
NS-4D-MRI (b) and 4D-CT (c) for an example patient.
4D-MRI with slab selective excitation clearly enhances
the imaging signal and improved the vessel CNR, com-
pared to NS-4D-MRI. SS-4D-MRI also results in visually
improved vessel CNR compared to 4D-CT. Relative
image intensity profiles (as shown in Fig. 3d, normalized
to the starting of the profile for each imaging technique),
also present the CNR enhancement in a quantitative
manner. The white straight line on the CT (3c) shows
the image region for the plotted profiles.
Table 1 summarizes basic clinical information, the
vessel-tissue CNR and correlation coefficients calculated
from motion trajectories of involved vessel and from
tumor for the patient cohort. Quantitative analysis
showed significantly improved CNRaorta of 23.0 ± 18.3
(mean ± SD) on SS-4D-MRI from 2.1 ± 2.0 on 4D-CT
with delayed contrast with a p value of 0.002. CNRIV also
significantly improved from 3.2 ± 2.7 on 4D-CT to 13.1
± 8.4 on SS-4D-MRI with a p value of 0.001. The mean
correlation coefficients (mean ± SD) calculated from
tumor and vessel motion trajectories were 0.93 ± 0.10,
0.65 ± 0.31 and 0.77 ± 0.23 in the SI, AP and ML direc-
tions respectively. Correlation coefficients for the SI dir-
ection are greater than 0.9 for all patients except two
(CC = 0.81 and 0.69), which might be a result of local
anatomical deformation of the tumor in the vessel re-
gions or small motion amplitudes for these two patients.
For this patient cohort, tumor moves more than in-
volved vessels, with SI motion range of 3.6 ± 1.5 mm
Yang et al. Radiation Oncology  (2018) 13:191 Page 3 of 8
Fig. 1 Example 4D-MRI images in coronal, sagittal and axial planes showing the tumor (red circle) and infiltrated blood vessels (green arrows)
Fig. 2 Example 4D-MRI coronal images at (a). end-of-inhalation (EOI), (b). mid-ventilation, and (c). end-of-exhalation (EOE) bins; (d-f) show the
motion trajectories derived from the tumor (red) and involved vessel (green) in the superior-inferior, anterior-posterior and
medial-lateral directions
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Fig. 3 Example images from slab-selective 4D-MRI (a), non-slab-selective 4D-MRI (b) and 4D-CT (c) for the same patient. Red circle indicates the
tumor region and green arrow indicates the involved blood vessel. d The relative image intensity profile across the tumor and aorta interface
indicated by the white line on the 4D-CT image in (c), with slab-selective-4D-MRI showing higher contrast across the tumor/vessel interface than
that non-slab-selective-4D-MRI and 4D-CT
Table 1 Patient characteristics, motion range, comparison of contrast to noise ratio, and correlation coefficient of tumor and vessel
motion trajectories
Patient
ID
Gender Age GTV
(cc)
GTV SI
motion
(mm)
IV SI
motion
(mm)
SS-4D-MRI / 4D-CT ICC (PTV vs. involved vessels) on SS-4D-MRI
CNR aorta CNR IV SI AP ML
1 M 54 220 3.7 3.2 13.2 / 0.7 11.2 / 2.9 0.99 0.18 0.97
2 M 79 53 4.2 3.5 13.5 / 0.3 4.6 / 0.7 1.00 0.44 0.42
3 M 69 100 3.3 2.5 43.8 / 7.3 27.5 / 5.8 0.96 0.88 0.96
4 M 79 38 3.8 2.4 14.5 / 1.0 4.7 / 1.6 0.99 0.93 0.87
5 F 48 58 1.5 1.1 32.0 / 0.8 23.1 / 0.8 0.81 0.44 0.94
6 M 69 48 2.3 1.5 6.2 / 2.0 6.9 / 0.3 0.93 0.72 0.44
7 M 67 87 4.8 4.6 14.8 / 1.4 9.1 / 1.4 0.99 0.98 0.63
8 F 79 125 2.3 0.1 18.7 / 1.7 11.9 / 6.5 0.69 0.11 1.00
9 M 34 112 7.3 7.6 64.2/ 1.9 23.5 / 7.6 1.00 0.92 0.93
10 F 72 14 3.0 2.3 9.5 / 3.8 8.7 / 4.4 0.97 0.85 0.52
Average n/a 65 86 3.6 2.9 23.0 / 2.1 13.1 / 3.2 0.93 0.65 0.77
Stdev n/a 14.3 55.8 1.5 2.1 18.3 / 2.0 8.4 / 2.7 0.10 0.31 0.23
p n/a n/a n/a n/a n/a 0.002* 0.001* n/a n/a n/a
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(mean ± SD) vs. 2.9 ± 2.1 mm for tumor and vessels
respectively.
Discussion
Despite the poor prognosis, evidence suggests that pan-
creas tumor respond to sufficiently high radiation dose
[21]. The dose is often excluded by sensitive nearby or-
gans. As shown in Fig. 4, pancreas is surrounded by
major blood vessels that supply nutrients and oxygen to
the organs nearby. Tumors grown on the pancreas head
and/or body usually wrap around these vessels such as
superior mesenteric artery and superior mesenteric vein
that prevent the surgical procedures. SBRT with SIB to
the cancerous regions around the vessels can be de-
signed to specifically sterilize the tumor non-invasively,
although the complete control of the whole tumor is
limited by the radiation dose tolerable by the normal
critical organs nearby. Down-staging the patients after
controlling the tumor around the vessels is the key to
the success of the margin negative resection post radi-
ation therapy. Therefore, radiation therapy with simul-
taneously integrated boost to the infiltrated blood
vessels has attracted increasing interest for its potential
to improve the resectability conversion rate and
long-term disease free survival for the pancreas cancer
patients who did receive subsequent margin negative re-
section. However, SIB of a moving target is challenging
even with image guided radiation therapy (IGRT). Lack
of image quality to differentiate soft tissue tumor and in-
volved blood vessels in current clinical IGRT practice,
which uses 4D-CT to evaluate pancreas tumor motion,
calls for novel and advanced imaging strategies with high
isotropic resolution, reduced imaging artifacts and im-
proved soft tissue contrast. To our knowledge, this study
is the first one that implements such a 4D-MRI se-
quence with the intent of characterizing not only the
tumor motion, but also the motion of tumor infiltrating
blood vessels. The key feature of this novel non-contrast
4D-MRI sequence is the fact that it can distinguish be-
tween motion of the vessels and the rest of the tumor.
Another key feature is the ability to significantly improve
the vessel conspicuity, which was extremely poor in
non-vessel highlighting 4D-MRI or non-contrast 4D-CT
images. The remarkable improvement in vessel contrast
Fig. 4 Schematic presentation of slab-selective excitation region and the local anatomies around pancreas with major vessels that limit the
resectability. Magenta circle indicates the tumor region that normally seen for locally advanced or borderline resectable pancreatic
cancer patients
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can help clinicians better identify and analyze the boost vol-
ume margin in the pancreas SBRT-SIB. The sequence uses
slab-selective excitation during image acquisition with a 3D
radial Koosh-Ball like sampling trajectory, which takes ad-
vantage of the fresh in-flow blood to enhance the blood sig-
nal. The vessel contrast enhancement only relies on the
natural blood flow of the patients, so no additional contrast
agent is needed. This feature makes frequent imaging pos-
sible for treatment strategies such as adaptive radiation
therapy in which fast daily motion assessments prior to ra-
diation dose delivery are preferred. Recent development in
tumor response assessment using 4D imaging modalities
potentially can also benefit from this novel 4D-MRI se-
quence with more frequent longitudinal 4D imaging data
becoming available.
This study also contributes to the recent emergence of
MRI-only simulation for radiotherapy treatment planning.
Besides its superior soft-tissue contrast as compared to
CT, other benefits of MRI including functional and dy-
namic imaging for tumor delineation and motion assess-
ment without radiation dose are well acknowledged by the
radiation therapy society. Both the tumor and involved
Advancement in 4D-MRI sequence including our vessel
highlighting 4D-MRI will facilitate the MR-only simula-
tion being implemented in radiation therapy.
One drawback of this study is the imaging recon-
struction speed. It takes around 8 h for our in-house
developed program to reconstruct and post-process a
KB 4D-MRI data set on a server equipped with
12-core Intel (Beaverton, OR) Xeon central processing
unit and 96 GB of memory. The speed of image re-
construction and imaging processing needs to be sig-
nificantly improved for wide clinical adaptation. There
are several methods that can be implemented to
speed up the image reconstruction. One example is to
use fast iterative shrinkage-thresholding algorithm
(FISTA), which preserves the computational simplicity
of iterative shrinkage-thresholding algorithms but with
a global rate of convergence which is proven to be
significantly better theoretically and practically [22].
Working closely with the MRI vendors to implement
the sequence will also help adapting the sequence
with more practical reconstruction time in a real clin-
ical setting.
Conclusion
A novel 4D-MRI sequence based on 3D-radial sampling
and slab-selective excitation has been assessed on pan-
creas cancer patients. The non-contrast 4D-MRI images
showed significantly better contrast to noise ratio for the
vessels that limit tumor resectability compared to
4D-CT with delayed contrast. The sequence has great
potential in accurately defining both the tumor and
boost volume margins for pancreas SBRT-SIB.
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